Work

ChemInform Abstract: 6‐Bicyclopiperazinyl‐1‐arylsulfonylindoles and 6‐Bicyclopiperidinyl‐1‐arylsulfonylindoles Derivatives as Novel, Potent, and Selective 5‐HT6 Receptor Antagonists.